Figure 6.

The dose-effect relationship between polydatin and cPLA2 mRNA expression in rat lung. A. cPLA2 mRNA expression in PD treatment groups with different doses by real-time PCR. B. cPLA2 mRNA expression in PD pretreatment groups with different doses by real-time PCR. cP < 0.01 vs. 1 mg·kg-1 PD group, eP < 0.05 and fP < 0.01 vs. 5 mg·kg-1PD group, and iP < 0.05 vs. 10 mg·kg-1 PD group.

Shiyu et al. BMC Cell Biology 2011 12:31   doi:10.1186/1471-2121-12-31
Download authors' original image